Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €78.60 Price Target by JPMorgan Chase & Co. Analysts

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €78.60 ($91.40) target price by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Thursday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 28.64% from the company’s current price.

FME has been the subject of a number of other research reports. Credit Suisse Group set a €71.00 ($82.56) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Thursday, August 1st. Deutsche Bank set a €100.00 ($116.28) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Wednesday, July 31st. HSBC set a €77.00 ($89.53) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Friday, August 30th. Nord/LB set a €82.00 ($95.35) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Thursday, August 1st. Finally, UBS Group set a €92.00 ($106.98) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Tuesday, July 30th. Seven investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of €79.03 ($91.90).

Shares of FME opened at €61.10 ($71.05) on Thursday. The company has a current ratio of 0.99, a quick ratio of 0.63 and a debt-to-equity ratio of 105.17. The stock has a market cap of $18.50 billion and a P/E ratio of 15.16. The company has a 50-day moving average of €61.17 and a two-hundred day moving average of €66.64. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €55.44 ($64.47) and a 12-month high of €76.68 ($89.16).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Story: Gap Up Stocks

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.